DR. JAMES RICHARD BERENSON M.D. NPI 1124051560

NPI Information

  • NPI: 1124051560
  • Provider Name: DR. JAMES RICHARD BERENSON, M.D.
  • Classification: Specialist - 1744R1102X
  • Specialization: Research Study
  • Entity Type: Individual
  • PECOS Registration: Yes
  • CLIA Number: 05D1031557
  • Address: 9201 W SUNSET BLVD
    SUITE 310
    WEST HOLLYWOOD, CA
    ZIP 90069
  • Phone: (310) 623-1222

Map and Directions

Get Directions

NPI Details

DR. James Richard Berenson, M.D. is a research study specialist in West Hollywood, CA with 49 years of experience. DR. James Richard Berenson, M.D. NPI is 1124051560. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

9201 W SUNSET BLVD
SUITE 310
WEST HOLLYWOOD, CA
ZIP 90069-701
Phone: (310) 623-1222
Fax: (310) 623-1123

The NPI 1124051560 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 05D1031557 - physician office with a certificate type of Certificate of Accreditation.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, elotuzumab, 1 mg (HCPCS:J9176)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, carfilzomib, 1 mg (HCPCS:J9047)
  • Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, isatuximab-irfc, 10 mg (HCPCS:J9227)
  • Injection, bortezomib, not otherwise specified, 0.1 mg (HCPCS:J9044)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Protein measurement, serum (HCPCS:84165)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Unclassified drugs (HCPCS:J3490)
  • Phosphate level (HCPCS:84100)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Administration of chemotherapy into vein using push technique (HCPCS:96409)
  • Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg (HCPCS:Q2050)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Uric acid level, blood (HCPCS:84550)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Amylase (enzyme) level (HCPCS:82150)
  • Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 7/9/2006 and was last updated on 9/11/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1174400000XSpecialistG42018CALIFORNIANo
21744R1102XSpecialistResearch StudyG42018CALIFORNIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
100G420180MEDICAIDCALIFORNIA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.